Assessment of protection against malaria by sporozoite challenge of healthy adults vaccinated with AdCh63 ME-TRAP and MVA ME-TRAP.

Trial Profile

Assessment of protection against malaria by sporozoite challenge of healthy adults vaccinated with AdCh63 ME-TRAP and MVA ME-TRAP.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 30 Jun 2012

At a glance

  • Drugs ME-TRAP malaria DNA vaccine Okairos (Primary)
  • Indications Malaria
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Jun 2012 Actual initiation date (29 Apr 2008) added as reported by European Clinical Trials Database.
    • 30 Jun 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 30 Jun 2012 Planned end date 26 Nov 2008 added as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top